Van ECK Associates Corp Acquires 27,590 Shares of Ventas, Inc. $VTR

Van ECK Associates Corp raised its stake in shares of Ventas, Inc. (NYSE:VTR) by 12.8% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 243,156 shares of the real estate investment trust’s stock after acquiring an additional 27,590 shares during the period. Van ECK Associates Corp owned approximately 0.05% of Ventas worth $17,018,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in VTR. BI Asset Management Fondsmaeglerselskab A S boosted its stake in shares of Ventas by 97.7% in the 3rd quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock worth $2,570,000 after buying an additional 18,146 shares during the last quarter. Investment Management Corp of Ontario lifted its holdings in Ventas by 1,019.0% in the second quarter. Investment Management Corp of Ontario now owns 133,061 shares of the real estate investment trust’s stock valued at $8,403,000 after acquiring an additional 121,170 shares during the period. Hudson Bay Capital Management LP purchased a new position in Ventas in the second quarter worth about $17,568,000. SCS Capital Management LLC bought a new stake in shares of Ventas during the 2nd quarter valued at about $13,788,000. Finally, Aberdeen Group plc increased its position in shares of Ventas by 8.3% during the 3rd quarter. Aberdeen Group plc now owns 1,580,923 shares of the real estate investment trust’s stock valued at $109,985,000 after purchasing an additional 120,825 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors.

Ventas Price Performance

Shares of VTR traded up $0.45 during mid-day trading on Friday, reaching $86.65. The stock had a trading volume of 721,015 shares, compared to its average volume of 2,861,053. The firm has a market cap of $41.15 billion, a price-to-earnings ratio of 160.59, a PEG ratio of 2.09 and a beta of 0.73. Ventas, Inc. has a 12 month low of $60.15 and a 12 month high of $87.87. The business has a fifty day moving average of $81.27 and a 200 day moving average of $76.19. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The firm had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the previous year, the business earned $0.81 earnings per share. The firm’s revenue for the quarter was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities analysts predict that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a $0.52 dividend. The ex-dividend date is Tuesday, March 31st. This is a positive change from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. Ventas’s dividend payout ratio (DPR) is presently 355.56%.

Insider Activity

In other news, CEO Debra A. Cafaro sold 10,322 shares of the company’s stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at $6,184,175. This represents a 32.81% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 86,106 shares of company stock worth $6,931,397 over the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

VTR has been the topic of a number of research reports. KeyCorp raised their price objective on shares of Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Wells Fargo & Company increased their price target on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Mizuho lifted their price target on shares of Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 4th. Jefferies Financial Group reissued a “buy” rating and set a $93.00 price objective on shares of Ventas in a research report on Monday, December 15th. Finally, Morgan Stanley set a $90.00 target price on Ventas in a report on Friday, February 13th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.00.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.